Cite
Supplementary Figure 9 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
MLA
George Zogopoulos, et al. Supplementary Figure 9 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22476441.v1.
APA
George Zogopoulos, Steven Gallinger, Jennifer J. Knox, Sandra E. Fischer, Grainne M. O’Kane, Talia Golan, William D. Foulkes, Paz Polak, Celia M.T. Greenwood, James Biagi, David Valenti, Louis-Martin Boucher, Tatiana Cabrera, Nathaniel Bouganim, Jamil Asselah, Yasser Riazalhosseini, Zu-Hua Gao, Julie M. Wilson, John M.S. Bartlett, … Yifan Wang. (2023). Supplementary Figure 9 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer. https://doi.org/10.1158/1078-0432.22476441.v1
Chicago
George Zogopoulos, Steven Gallinger, Jennifer J. Knox, Sandra E. Fischer, Grainne M. O’Kane, Talia Golan, William D. Foulkes, et al. 2023. “Supplementary Figure 9 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer,” March. doi:10.1158/1078-0432.22476441.v1.